MAPT and Alzheimer disease: For instance, HSP40 and HSP70 are able to inhibit the formation of Aβ plaques by refolding the excessive Aβ peptides into soluble forms, while HSP90 facilitates the pathogenic folding of tau protein into neurotoxic tangles, thus promoting AD progression (Ciechanover & Kwon, 2017).